The compound (Scheme I) belongs to a series of cyano-pyridinones that have been evaluated for their anticancer properties (Rostom et al., 2011). The tetrahydrobenzo[h]quinoline fused-ring system is buckled owing to the ethylene -CH 2 CH 2fragment, the benzene ring and the pyridine ring being twisted by 19.7 (1)°. The 4-subsituted aromatic ring is bent away from the pyridine ring by 62.9 (1) ° in order to avoid crowding the cyanide substituent ( Fig. 1) . Two molecules are linked by an N-H···O hydrogen bonds to form a centrosymmetric dimer (Table 1) .
In the molecule of the title compound, C 20 H 14 N 2 O, the tetrahydrobenzo[h]quinoline fused-ring system is buckled owing to the ethylene -CH 2 CH 2 -fragment, the benzene ring and the pyridine ring being twisted by 19.7 (1) . The 4-substituted aromatic ring is bent away from the pyridine ring by 62.9 (1) in order to avoid crowding the cyanide substituent. In the crystal, two molecules are linked by a pair of N-HÁ Á ÁO hydrogen bonds to form a centrosymmetric dimer.
Related literature
The title compound belongs to a series of cyano-pyridinones that have been evaluated for their anticancer properties, see: Rostom et al. (2011) . Table 1 Hydrogen-bond geometry (Å , ).
Experimental
Symmetry code: (i) Àx þ 1; Ày þ 1; Àz þ 1.
Data collection: CrysAlis PRO (Agilent, 2010); cell refinement: CrysAlis PRO; data reduction: CrysAlis PRO; program(s) used to solve structure: SHELXS97 (Sheldrick, 2008); program(s) used to refine structure: SHELXL97 (Sheldrick, 2008); molecular graphics: X-SEED (Barbour, 2001); software used to prepare material for publication: publCIF (Westrip, 2010). 
